Corpus Intelligence IC Memo — SAINT FRANCIS HOSPITAL SOUTH 2026-04-26 04:00 UTC
IC Memo — SAINT FRANCIS HOSPITAL SOUTH
Investment Committee Memorandum | OK | 104 beds | Grade C | EBITDA uplift $14.6M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

SAINT FRANCIS HOSPITAL SOUTH

CCN 370218 | TULSA, OK | 104 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

SAINT FRANCIS HOSPITAL SOUTH is a 104-bed suburban community hospital in TULSA, OK with $198.3M in net patient revenue and a 34.4% operating margin. The hospital serves a payer mix of 25.6% Medicare, 24.2% Medicaid, and 50.2% commercial.

Thesis: Turnaround. Our ML models identify $14.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 34.4% to 41.7% (+736bps).

Net Revenue HCRIS$198.3M
Current EBITDA COMPUTED$68.1M
Operating Margin COMPUTED34.4%
Occupancy HCRIS67.7%
Revenue / Bed COMPUTED$1.9M
Net-to-Gross HCRIS28.3%
Distress Probability ML47.8%

2. Market Context & Competitive Position

147
OK Hospitals
-8.8%
State Median Margin
41
Comparable Hospitals

OK has 147 Medicare-certified hospitals with a median operating margin of -8.8%. The target's margin of 34.4% places it above the state median. Among 41 size-comparable peers (52-208 beds), the median margin is -3.8%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (52-208), prioritizing same-state peers. 41 hospitals in the comp set.

HospitalStateBedsRevenueMargin
SAINT FRANCIS HOSPITAL SOUTH (Target)OK104$198.3M34.4%
OKLAHOMA HEART HOSPITALOK97$342.0M-2.8%
COMANCHE COUNTY MEMORIAL HOSPIOK201$304.2M-7.9%
STILLWATER MEDICAL CENTEROK52$270.2M-9.9%
INTEGRIS SOUTHWEST MEDICAL CENOK169$267.6M-13.5%
HILLCREST HOSPITAL SOUTHOK152$218.9M4.9%
ST ANTHONY SHAWNEE HOSPITALOK57$169.2M-6.1%
MCBRIDE CLINIC ORTHOPEDIC HOSPOK68$166.9M-5.0%
MERCY HOSPITAL ARDMOREOK140$158.8M-1.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $14.6M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$4.2M+210bp18mo
Cost to Collect4.5%2.5%$4.0M+200bp12mo
Denial Rate Reduction12.0%6.5%$3.9M+198bp12mo
A/R Days Reduction5200.0%3800.0%$2.4M+122bp9mo
Clean Claim Rate88.0%96.0%$127K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$4.2M
Cost to Collect
$4.0M
Denial Rate Reduction
$3.9M
A/R Days Reduction
$2.4M
Clean Claim Rate
$127K
Total EBITDA Uplift$14.6M
Current EBITDA$68.1M
+ RCM Uplift+$14.6M
Pro Forma EBITDA$82.7M
Current Margin34.4%
Pro Forma Margin41.7%
WC Released (1x)$7.6M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$104.8M$595.4M5.68x41.5%
Base (11x exit)10.0x11.0x$104.8M$689.0M6.57x45.7%
Bull Case9.0x11.0x$94.3M$771.2M8.17x52.2%
Bull (12x exit)9.0x12.0x$94.3M$869.2M9.21x55.9%
Bear Case11.0x10.0x$115.3M$488.4M4.24x33.5%
Bear (11x exit)11.0x11.0x$115.3M$574.7M4.98x37.9%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumElevated Medicaid exposure (24.2%)Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 41 hospitals with 52-208 beds
  • Same-state prioritization (n=42)
  • Comp margins: P25=-15.2% / P50=-3.8% / P75=6.0%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.